Prescription drug · ANDA
Haloperidol decanoate NDC 70710-1461
Haloperidol decanoate 50 mg/mL · Injection · Intramuscular · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-1461-6 | 7071014610670710146106 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-6) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 14, 2019 | |
| 70710-1461-9 | 7071014610970710146109 | 3 VIAL, SINGLE-DOSE in 1 CARTON (70710-1461-9) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 14, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Haloperidol decanoate
- Generic name (nonproprietary)
- haloperidol decanoate
- Active ingredients
- Haloperidol decanoate — 50 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular
- Labeler
- Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211180
- Marketing start
- Listing expires
- Identifiers
- Product ID 70710-1461_b06b16a2-177a-4bd6-b1fa-80d1be6acfb8SPL ID b06b16a2-177a-4bd6-b1fa-80d1be6acfb8SPL set ID 6d2d7612-ad47-4ee7-a42c-945c976d947bRxCUI 859867, 859871, 1719803, 1719862UNII AC20PJ4101
- Pharmacologic class
- Typical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470710146106followed by a unit qualifier and the quantityPackage 70710-1461-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Haloperidol decanoate is indicated for the treatment of schizophrenia in adults who were previously taking a stable dosage of an immediate-release oral haloperidol product. Haloperidol decanoate is a typical antipsychotic indicated for the treatment of schizophrenia in adults who were previously taking a stable dosage of an immediate-release oral haloperidol product ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 70710-1461
- What is NDC 70710-1461?
- 70710-1461 is the product NDC for Haloperidol decanoate, Haloperidol decanoate 50 mg/mL injection, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Haloperidol decanoate.
- What is the active ingredient?
- Haloperidol decanoate.
- Who is the labeler?
- Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Haloperidol decanoate?
- 55 other product NDCs are listed under this name. See all Haloperidol decanoate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Haloperidol decanoate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | REMEDYREPACK INC. | 70518-4670 | 70518-4670-00 |
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | Armas Pharmaceuticals Inc. | 72485-520 | 72485-0520-10 |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Armas Pharmaceuticals Inc. | 72485-521 | 72485-0521-10 |
| Haloperidol Decanoate | Haloperidol decanoate 500 mg/5mL | InjectionIntramuscular | Armas Pharmaceuticals Inc. | 72485-522 | 72485-0522-01 |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | REMEDYREPACK INC. | 70518-4584 | 70518-4584-00 |
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | Somerset Therapeutics, LLC | 70069-866 | 70069-0866-10 |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Somerset Therapeutics, LLC | 70069-867 | 70069-0867-05 |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Somerset Therapeutics, LLC | 70069-868 | 70069-0868-01 |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | BluePoint Laboratories | 68001-657 | 68001-0657-51 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | BluePoint Laboratories | 68001-658 | 68001-0658-4168001-0658-52 |
Other NDCs under ANDA 211180
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | BluePoint Laboratories | 68001-657 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | BluePoint Laboratories | 68001-658 |
| Haloperidol decanoate | Haloperidol decanoate 500 mg/5mL | InjectionIntramuscular | BluePoint Laboratories | 68001-659 |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | Zydus Pharmaceuticals USA Inc. | 70710-1462 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Zydus Pharmaceuticals USA Inc. | 70710-1463 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Zydus Pharmaceuticals USA Inc. | 70710-1464 |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1851 |
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1852 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1853 |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | Zydus Lifesciences Limited | 70771-1854 |